Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
Making a true impact with the results from today's clinical trials depends on integrating a flow of data that supports automation and complies with standards. The trend toward decentralized clinical trials accelerates the need for such a datadriven system. Such trials simplify patient participation and allow study teams and sponsors to benefit from remote monitoring of close-to-real-time data.
Selecting the right data ecosystem before starting a trial makes all the difference in running an efficient and effective study. The best choice is an end-to-end solution that accommodates project management,; IT solutions, global logistics, scientific expertise, data management, global site support, and biostatistics.
IQVIA's eSource platform connects devices to improve study participation and develop deeper insights from the data. For example, eSource allows participants to use devices that simplify data collection and reduce manual steps. Likewise, sponsors benefit from the automation that collects high-quality data that complies with regulatory standards. This platform flexibly collects data from disparate devices—such as Bluetooth and cloud-based devices—from locations around the world. This system also helps a sponsor with the setup of a clinical trial and training at study sites, and it includes standard; forms for device integration and data collection. Using Study Data Tabulation Model (SDTM) standards allows deeper data analysis. The data can also be taken from collection to publication through this platform. Integrating so many features leads to cleaner data and a more efficient clinical trial. Crucially, the data moves in close to real time from a patient, even one monitored at home, to the eSource platform.
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
Change the model of clinical research by integrating data, expertise, analytics and technology from study design through execution to power better decisions.
Improve the performance of your clinical trials with the power of the IQVIA CORE.
Getting the right outcomes from your clinical trials is all about the data and insights they provide. Biostatistics in clinical trials isn’t just a necessity, it can be a real competitive advantage.